oral semaglutide 50 mg Study reveals as promising treatment for obesity in adults: the Lancet report Novo Nordisk wins EU approval

While both target weight loss through different mechanisms, dual therapy carries cardiovascular and metabolic risks that demand provider oversight and individual assessment before proceeding

It seems as though Ozempic and other weight-loss jabs are everywhere and the appetite for them shows no signs of slowing down with the industry accelerating so fast its projected to be worth $100...

GLP-2, marketed under the brand name Mounjaro, represents a groundbreaking advancement in the management of Type 2 diabetes and obesity

Rudy Bilous,MD, FRCP Richard Donnelly,MD, PHD, FRCP, FRACP Etiology and clinical presentation Hypoglycemia is a common side effect of treatment

Discover tips, and dietary adjustments to alleviate discomfort and ensure a smoother treatment journey.

Compare Tirzepatide and Semaglutide for weight loss with Dr Glenn Lyle in Raleigh NC